VR rehabilitation for motor function
Otherrehabilitation for motor function
Other names: VR rehabilitation therapy
NCT Number: NCT03502122
This study aims to design and verify a multi-mode smart assistive device system for Stroke Rehabilitation by using EEG, fMRI, IMU and questioners
Looking for future studies?
Notify Me20 year–85 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
rehabilitation for motor function
Other names: VR rehabilitation therapy
Time frame: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )
FUGL- MEYER ASSESSMENT OF PHYSICAL PERFORMANCE (FMA)
Time frame: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )
upper extremity performance evaluation test for the elderly (TEMPA)
Time frame: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )
Brunnstrom stage
Time frame: pre, post (after 24 hrs of intervention) and follow-up (one month after finishing intervention )
Wolf motor function
National Central University, Taiwan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details